Andrew Rowland

Accommodation inspection toolkit

Andrew Rowland, 2008 .

Carno Dam Case History of Investigation and Remedial Works

Clif Kettle, Vojtech Vrba, Andrew Rowland, 2012 .

Performance. Go your own way.

Andrew Rowland, 2009, The Health service journal.

Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions

John O. Miners, Andrew Rowland, A. Rowland, 2015, Drug Metabolism and Disposition.

The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification.

Andrew Rowland, A. Rowland, J. Miners, 2013, The international journal of biochemistry & cell biology.

IN VITRO CHARACTERIZATION OF LAMOTRIGINE N2-GLUCURONIDATION AND THE LAMOTRIGINE-VALPROIC ACID INTERACTION

Andrew Rowland, A. Rowland, J. Miners, 2006, Drug Metabolism and Disposition.

The “Albumin Effect” and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 Activities

Andrew Rowland, K. Knights, A. Rowland, 2008, Drug Metabolism and Disposition.

Pharmacogenomic substudies of randomized controlled trials: consideration of safety outcomes

Andrew Rowland, M. Wiese, A. Rowland, 2014, Therapeutic advances in drug safety.

Binding of Inhibitory Fatty Acids Is Responsible for the Enhancement of UDP-Glucuronosyltransferase 2B7 Activity by Albumin: Implications for in Vitro-in Vivo Extrapolation

Andrew Rowland, K. Knights, A. Rowland, 2007, Journal of Pharmacology and Experimental Therapeutics.